Reports, Notices, Documents

Meeting Synopsis and Slide Presentations Carcinogen Identification Committee Meeting Held on October 12, 2011

11/02/2011

Extension of Comment Period - Proposed Amendment To Section 25707(B), Route of Exposure: Hexavalent Chromium (VI)

10/31/2011

tris(1,3-dichloro-2-propyl) phosphate (TDCPP) Listed Effective October 28, 2011 as Known to the State to Cause Cancer

10/28/2011

Hearing - Proposed Amendment To Section 25705 Specific Regulatory Levels Posing No Significant Risk: Imazalil

10/27/2011

Notice of Adoption to Text of Regulations Title 27, California Code of Regulations Amendment to Section 25805 Maximum Allowable Dose Level (MADL) for Avermectin B1

10/26/2011

Extension of Comment Period - Changed Notice of Proposed Rulemaking Specific Regulatory Levels Posing No Significant Risk: 4-Methylimidazole (4-MEI)

10/24/2011

Carcinogen Identification Committee Meeting Scheduled for October 12 and 13, 2011

10/12/2011

Comment Period - Changed Notice of Proposed Rulemaking Specific Regulatory Levels Posing No Significant Risk: 4-Methylimidazole (4-MEI)

10/07/2011

Notice of Augmentation of Record and 2nd Modification of Text of Proposed Regulation Title 22, California Code of Regulations, Sections 69401 Through 69407 Green Chemistry Hazard Traits for California’s Toxics Information Clearinghouse

10/07/2011

Changed Notice of Proposed Rulemaking Specific Regulatory Levels Posing No Significant Risk: 4-Methylimidazole (4-MEI)

10/07/2011